What is Global Wellness Strategies Inc. (GWSFF) stock price today?

Global Wellness Strategies Inc. (GWSFF) is currently trading at $0.12, up 55.5% today.

What is GWSFF P/E ratio?

Global Wellness Strategies Inc.'s P/E ratio is -1.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GWSFF return on equity (ROE)?

Global Wellness Strategies Inc.'s return on equity (ROE) is 281.20%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Global Wellness Strategies Inc.'s market cap?

Global Wellness Strategies Inc. has a market capitalization of $6.12M.

OTC · Financial - Credit Services

Global Wellness Strategies Inc. (GWSFF) Stock

$0.12 +55.50% OTC: GWSFF Financial Services

Valuation

Metric	Value
Price	$0.12
Market Cap	$6.12M
P/E Ratio	-1.00
P/B Ratio	-3.03
P/S Ratio	0.00
EPS (TTM)	$-0.05
52-Week High	$0.32
52-Week Low	$0.04
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	281.20%
ROA	-455.96%
ROCE	326.02%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.06
Current Ratio	0.41

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-3.0M	$-3.0M	$-1.0M	$-4.0M	$-1.0M
Net Profit	$-3.0M	$-2.0M	$-1.0M	$-4.0M	$-1.0M
EPS	$-0.35	$-0.20	$-0.10	$-0.23	$-0.05
Op Margin	—	-2412.7%	-585.0%	—	—

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$1.0M	$1.0M	$0	$0	$0
Total Liabilities	$0	$0	$0	$1.0M	$1.0M
Cash	$1.0M	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Latest News

Absa updates credit risk systems with SAS Retail Banker International · Aug 5, 2026 Stocks mostly rise tracking earnings, US-Iran hopes AFP · Aug 5, 2026 SpaceX And Tesla Earnings Have A Similar Theme: Capex Spending Investor's Business Daily · Aug 5, 2026 Podcast: RevealDx’s CEO on the global radiologist shortage Medical Device Network · Aug 5, 2026 Michael Burry warns of 1987-style crash, holds Nvidia shorts Quartz · Aug 5, 2026

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-1.0M	$-1.0M	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$2.0M	$0	$0	$0	$0
Net Cash Flow	$1.0M	$-1.0M	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.80
FCF Yield	-17.32%
Quick Ratio	0.41
Interest Coverage	126.99
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASNBEKIMAS Corporation	$0.85	+6.58%	-6.23	$4.83M	0.00%
EATBFEat & Beyond Global Holdings Inc.	$0.08	-1.37%	-1.73	$4.61M	0.00%
EZRGEZRaider Co.	$1.00	+0.00%	-15.48	$41.99M	0.00%
GDVMGlobal Developments, Inc.	$0.01	-1.59%	—	$2.28M	0.00%
LWLWLongwen Group Corp.	$0.10	+0.00%	-10.31	$8.09M	0.00%

About Global Wellness Strategies Inc.

Global Wellness Strategies Inc., formerly known as Redfund Capital Corp., operates as an incubation and acceleration specialist focused on nurturing the growth of emerging businesses. The company strategically allocates its capital, targeting investments in both publicly traded and privately held entities within Canada. Its primary investment focus lies in ventures dedicated to preventative health, overall wellness, and related consumer goods. In addition to its equity investments, the firm also extends debt financing facilities. Established in 1998, Global Wellness Strategies Inc. is headquartered in Vancouver, Canada.

Global Wellness Strategies Inc. is headquartered in CA.

Global Wellness Strategies Inc. (GWSFF) stock trades at $0.12 with a market capitalization of $6.12M. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of -3.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.04 and $0.32, and currently trades 62.5% below its 52-week high.

On profitability, Global Wellness Strategies Inc. generates a return on equity (ROE) of 281.20% — well above the market average, a sign of a high-quality business, return on capital employed of 326.02%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: xtacytherapeutics.com